U.S. Pharmacist Weekly News
March 27, 2024

No Significant Stroke Risk After Bivalent Vaccines in Older Adults

Several studies have voiced concerns about stroke risk after COVID-19 vaccination, and federal agencies raised the specter in January 2023. A new case series study from the FDA should allay most of the worries, however, finding no significant elevation of stroke risk in older recipients up to 42 days after being vaccinated. Risk in specific circumstances appears to remain, however. Read more.

Advertisement

Lean Six Sigma: Helping Long-Term Care Pharmacies Thrive in a Challenging Market

To help Long-Term Care pharmacies meet the challenges of caring primarily for our aging population, Cardinal Health Operational Excellence Consulting offers Lean Six Sigma strategies to help enhance customer satisfaction, eliminate waste, and improve profitability. Learn more here.

Unvaccinated Travelers Behind Increase in U.S. Measles Cases

Children aged as young as 6 months need to receive the measles-mumps-rubella vaccine if their parents plan international travel with them, according to a new health alert warning about a sharp increase in measles cases in the United States. Find out the role played by international travel in the increase, especially if it involves unvaccinated travelers.

Advertisement

Tranexamic Acid May Be Beneficial for Postpartum Hemorrhage

The use of tranexamic acid may decrease the rate of postpartum hemorrhage; however, it was found that this fibrinolysis inhibitor was only administered in about 1% of postpartum hemorrhage cases in the United States. This low usage may be due to a lack of consensus surrounding the use of tranexamic acid in postpartum hemorrhage, especially in high-risk populations. Read more.

 
Facebook   Twitter   USP Google App   USP itunes App
U.S. Pharmacist
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Advertisement Advertisement